ArticlePharmaceutical biology2022

Sasanquasaponin inhibited epithelial to mesenchymal transition in prostate cancer by regulating the PI3K/Akt/mTOR and Smad pathways.

Wenfeng Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.